Castle Biosciences Inc (CSTL)

08:18 AM

When is the best time to exit Castle Biosciences Inc.Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com

08:18 AM

07:13 AM

Castle Biosciences, Inc. to Announce Third Quarter 2025 Financial Results on November 3 - Quiver Quantitative

07:13 AM

07:03 AM

Castle Biosciences to Release Third Quarter 2025 Financial - GlobeNewswire

07:03 AM

07:00 AM

Nov. 3 webcast: Castle Biosciences to release Q3 results and host conference call at 4:30 PM ET - Stock Titan

07:00 AM

04:02 AM

Will Castle Biosciences Inc. stock remain a Wall Street favoriteIPO Watch & Risk Controlled Swing Alerts - newser.com

04:02 AM

12:24 PM

Risk adjusted return profile for Castle Biosciences Inc. analyzedProfit Target & Daily Oversold Bounce Ideas - newser.com

12:24 PM

Oct 12, 2025

How high can Castle Biosciences Inc. stock go2025 Key Highlights & Weekly High Return Opportunities - newser.com

Oct 12, 2025

Oct 12, 2025

Using data tools to time your Castle Biosciences Inc. exitMarket Performance Report & Daily Price Action Insights - newser.com

Oct 12, 2025

Oct 11, 2025

New Data Demonstrates Significant & Risk-Appropriate Clinical Impact of DecisionDx-SCC Test Results on Patient Management Dec... - ADVFN

Oct 11, 2025

Oct 10, 2025

Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com

Oct 10, 2025

Oct 10, 2025

What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in

Oct 10, 2025

Oct 10, 2025

How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Oct 09, 2025

Oct 06, 2025

Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com

Oct 06, 2025

Oct 06, 2025

Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com

Oct 06, 2025

Oct 05, 2025

How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com

Oct 05, 2025

Oct 03, 2025

Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com

Oct 03, 2025

Oct 02, 2025

Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in

Oct 02, 2025

Oct 01, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - markets.businessinsider.com

Oct 01, 2025

Oct 01, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Oct 01, 2025

Oct 01, 2025

Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan

Oct 01, 2025

Oct 01, 2025

User - FinancialContent

Oct 01, 2025

Sep 29, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 29, 2025

Sep 27, 2025

What analysts say about Castle Biosciences Inc stockSmall Cap Stock Opportunities & High Profit Market Tips - Early Times

Sep 27, 2025

Sep 24, 2025

Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat

Sep 24, 2025

Sep 23, 2025

Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com

Sep 23, 2025

Sep 23, 2025

SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛

Sep 23, 2025

Sep 23, 2025

Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat

Sep 23, 2025

Sep 23, 2025

Castle Biosciences, Inc. $CSTL Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 23, 2025

Sep 23, 2025

Diagnostic Testing Leader Castle Biosciences Secures 9th Workplace Award in 2025, Including Pittsburgh Honor - Stock Titan

Sep 23, 2025

Sep 23, 2025

SciBase receives initial order for clinical study from Castle Biosciences - Yahoo Finance

Sep 23, 2025

Sep 23, 2025

Scibase receives initial order for clinical study from Castle Biosciences - MarketScreener

Sep 23, 2025

Sep 21, 2025

Inspire Investing LLC Has $343,000 Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat

Sep 21, 2025

Sep 20, 2025

Activity Recap: Does Castle Biosciences Inc have declining or rising EPSShare Buyback & Stepwise Trade Execution Plans - khodrobank.com

Sep 20, 2025